Chemed Corp (CHE) stock

CHENYSEServices-Home Health Care ServicesFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 17/305% above fair value

$550.62+6.13 (+1.13%)

Close on Nov 11, 2026Market cap $7.17BP/E 26.3Yield 0.40%

Chemed statistics

112 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Feb 24, 2027 (estimated, after the close)
Last ex-dividend date: Aug 17, 2026
Fundamentals through: Sep 30, 2026
Share price as of: Nov 11, 2026

Valuation ratiosIndustry

Market Cap: $7.17B; $1.70B
Enterprise Value: $7.35B; $2.27B
PE Ratio: 26.33; 23.83
PS Ratio: 2.69; 1.69
PB Ratio: 8.32; 3.68
P/TBV Ratio: 257.11; 6.58
P/FCF Ratio: 24.26; 21.11
P/OCF Ratio: 19.73; 14.94

Enterprise valuationIndustry

EV / Sales: 2.76; 1.70
EV / EBITDA: 16.77; 16.15
EV / EBIT: 19.83; 20.56
EV / FCF: 24.89; 24.63

Share statisticsIndustry

Shares Outstanding: 13M; 58M
Shares Change (YoY): -8.25%; 2.40%
Float: 13M; 34M
Shares Held by Insiders: 1.38%; 15.0%
Shares Held by Institutions: 104.1%; 85.9%

Short sellingIndustry

Short Interest: 795,988; –
Short Interest Change: 16.0%; -0.86%
Short % of Float: 6.20%; 6.29%
Short % of Shares Outstanding: 6.12%; 4.32%
Days to Cover: 5.05; 4.41

Stock price statisticsIndustry

52-Week High: $562.24; –
52-Week Low: $365.20; –
20-Day Moving Average: $527.41; –
50-Day Moving Average: $516.09; –
200-Day Moving Average: $466.41; –
Average True Range (14): $15.76; –
Price Change (1 Week): 0.36%; -3.47%
Price Change (1 Month): 9.95%; 0.80%
Price Change (3 Months): 2.50%; 2.71%
Price Change (6 Months): 29.9%; 19.5%
Price Change (YTD): 28.7%; 7.32%
Price Change (1 Year): 26.3%; 11.2%
Price Change (3 Years): -5.40%; 24.2%
Price Change (5 Years): 9.73%; -13.2%
Price Change (10 Years): 274.2%; 197.1%
Average Volume (10 Days): 171,940; –
Average Volume (20 Days): 160,878; –
Average Volume (90 Days): 158,119; –
Relative Volume: 1.20; 0.83
Relative Strength Index (14): 62.3; 48.6
Volatility (1 Year): 28.6%; 63.1%
Beta (5 Years): 0.35; 0.77

MarginsIndustry

Gross Margin: 33.5%; 33.3%
Operating Margin: 13.9%; -2.98%
Pretax Margin: 14.4%; 2.12%
Profit Margin: 10.6%; -2.01%
EBITDA Margin: 16.5%; 3.36%
FCF Margin: 11.1%; 2.98%

Returns on capitalIndustry

Return on Equity (ROE): 29.1%; 4.69%
Return on Assets (ROA): 16.9%; -3.06%
Return on Invested Capital (ROIC): 27.4%; 4.02%
Return on Capital Employed (ROCE): 26.7%; -0.53%

Financial positionIndustry

Current Ratio: 1.11; 1.41
Quick Ratio: 0.92; 0.98
Debt / Equity: 0.27; 0.69
Debt / EBITDA: 0.54; 2.57
Debt / FCF: 0.80; 4.04
Net Debt / EBITDA: 0.43; 2.14
Interest Coverage: 75.39; -0.63

GrowthIndustry

Revenue Growth (YoY): 5.15%; 9.30%
Net Income Growth (YoY): 1.29%; 16.5%
EPS Growth (YoY): 10.5%; 19.0%
FCF Growth (YoY): -18.0%; -6.64%
Revenue Growth (3Y CAGR): 5.82%; 11.3%
Revenue Growth (5Y CAGR): 4.00%; 12.6%
EPS Growth (3Y CAGR): 3.52%; 19.8%
EPS Growth (5Y CAGR): -1.20%; 9.29%

EfficiencyIndustry

Asset Turnover: 1.59; 0.81
Inventory Turnover: 221.26; 10.99
Revenue Per Employee: $168.30K; $235.26K
Profits Per Employee: $17.86K; -$8.39K
Employee Count: 15,811; 910
WACC: 7.26%; 8.13%

Income statement (TTM)Industry

Revenue: $2.66B; $638.13M
Gross Profit: $892.52M; $196.31M
Operating Income: $370.86M; -$1.81M
Pretax Income: $382.32M; -$575.82K
Net Income: $282.40M; -$1.48M
EBITDA: $438.45M; $960.38K
EPS (Diluted): $20.91; -$0.02

Balance sheetIndustry

Cash & Short-Term Investments: $48.43M; $90.01M
Total Debt: $236.00M; $246.10M
Net Cash (Debt): -$187.57M; $119.40K
Net Cash Per Share: -$14.41; $0.00
Equity (Book Value): $861.42M; $212.67M
Book Value Per Share: $66.19; $3.48
Tangible Book Value: $27.87M; $1.59M
Working Capital: $34.79M; $27.61M

Cash flow (TTM)Industry

Operating Cash Flow: $363.16M; $18.76M
Capital Expenditures: -$67.70M; -$15.83M
Free Cash Flow: $295.45M; $18.83M
FCF Per Share: $22.70; $0.36

Dividends and yieldsIndustry

Earnings Yield: 3.94%; -0.10%
FCF Yield: 4.12%; 2.54%
Dividend Yield: 0.40%; 0.54%
Buyback Yield: 7.32%; 0.45%
Shareholder Yield: 7.72%; 1.33%
Dividend Per Share: $2.20; $1.30
Dividend Growth (YoY): 22.2%; 4.55%
Years of Dividend Growth: 17; 4
Payout Ratio: 11.9%; 13.4%
FCF Payout Ratio: 11.4%; 11.9%

Taxes and interestIndustry

Interest Expense: $4.92M; $7.37M
Income Tax: $99.92M; $564.50K
Effective Tax Rate: 26.1%; 24.1%

Scores and fair valueIndustry

Graham Number: $176.46; $21.25
Graham Upside: -68.0%; -50.0%
Altman Z-Score: 9.86; 2.33
Piotroski F-Score: 6; 5
Beneish M-Score: -2.76; -2.76

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.

Period	CHE	S&P 500	Difference	CHE per year	S&P 500 per year
1 month	+10.2%	-2.4%	+12.6 pts
3 months	+2.6%	-1.2%	+3.8 pts
Year to date	+29.2%	+12.3%	+16.9 pts
1 year	+24.2%	+12.4%	+11.8 pts
3 years	-4.3%	+78.8%	−83.1 pts	-1.5%	+21.4%
5 years	+12.3%	+75.2%	−62.8 pts	+2.4%	+11.9%
10 years	+287.9%	+311.1%	−23.2 pts	+14.5%	+15.2%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

1M CHE shares were sold short on Oct 30, 2026, up 16.0% from the previous report, or 6.20% of the shares available to trade. At recent volumes it would take 5.0 days to buy them back. Over the last 20 sessions, 60.4% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	795,988	+16.0%	157,550	5.0
Oct 15, 2026	685,972	+15.0%	139,292	4.9
Sep 30, 2026	596,751	-8.6%	182,103	3.3
Sep 15, 2026	653,250	+15.7%	120,997	5.4
Aug 31, 2026	564,624	-11.6%	150,152	3.8
Aug 14, 2026	638,408	+38.4%	171,073	3.7
Jul 31, 2026	461,352	-18.5%	181,264	2.5
Jul 15, 2026	566,002	+0.3%	155,903	3.6
Jun 30, 2026	564,257	-6.3%	242,954	2.3
Jun 15, 2026	602,352	-5.5%	214,220	2.8
May 29, 2026	637,297	+1.1%	196,404	3.2
May 15, 2026	630,541	+20.1%	230,054	2.7